Low-Value Prostate Cancer Screening Common in Primary Care
TUESDAY, Jan. 10, 2023 (HealthDay News) -- Low-value prostate cancer screening is common in primary care, according to a study published in the January issue of the Journal of the American Board of Family Medicine.
Chris Gillette, Ph.D., from the Wake Forest School of Medicine in Winston-Salem, North Carolina, and colleagues used data from the National Ambulatory Medicare Care Survey (2013 to 2016 and 2018) to assess the proportion of U.S. primary care visits at which low-value prostate cancer screening is ordered, as well as characteristics associated with low-value prostate cancer screening.
The researchers found 6.71 low-value prostate-specific antigens (PSAs) per 100 visits and 1.65 low-value digital rectal exams (DREs) per 100 visits. The odds of ordering a low-value PSA increased by 49 percent and the odds of performing a low-value DRE increased by 37 percent for each additional service ordered by primary care providers.
"As health care systems move toward a more value-based care system -- where the benefit of services provided outweighs any risks -- providers need to engage patients in these discussions on the complexity of this testing," Gillette said in a statement. "Ultimately, when and if to screen is a decision best left between a provider and the patient."
Related Posts
Oklahoma Supreme Court Overturns $465 Million J&J Opioid Ruling
WEDNESDAY, Nov. 10, 2021 (HealthDay News) -- A previous court ruling that...
Pandemic Lockdowns May Have Slowed Babies’ Communication Skills
WEDNESDAY, Oct. 12, 2022 (HealthDay News) -- When social interaction came to a...
AHA News: These Healthy Habits Might Also Lead to a Happier Life
FRIDAY, March 17, 2023 (American Heart Association News) -- Is the secret to...
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important...